Vetnostrum Animal Health Co., Ltd. (TPE:6936)

Market Cap	2.52B -24.2%
Revenue (ttm)	1.42B +9.4%
Net Income	128.85M -5.7%
EPS	1.82 -11.7%
Shares Out	72.80M
PE Ratio	19.01
Forward PE	n/a
Dividend	1.33 (3.84%)
Ex-Dividend Date	Jul 16, 2025

Volume	50,030
Average Volume	36,548
Open	34.80
Previous Close	34.80
Day's Range	33.80 - 35.35
52-Week Range	33.55 - 46.90
Beta	0.16
RSI	43.11
Earnings Date	May 6, 2026

About Vetnostrum Animal Health

Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company was founded in 2012 and is based in Hsinchu City, Taiwan. Vetnostrum Animal Health Co., Ltd....

• Industry: Farm Products
• Sector: Consumer Staples
• Founded: 2012
• Employees: 195
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6936

Financial Performance

In 2025, Vetnostrum Animal Health's revenue was 1.42 billion, an increase of 9.43% compared to the previous year's 1.29 billion. Earnings were 128.85 million, a decrease of -5.68%.